Hot of the breath: mortality as a primary end-point in IPF treatment trials: the best is the enemy of the good

Wells AU;Behr J;Costabel U;Cottin V;Poletti V;Richeldi L;Albera C;Ancochea J;Antoniou KM;Bonella F;Bonniaud P;Bouros D;Bresser P;Cordier JF;Crestani B;Domagala Kulawik J;Drent M;Egan JJ;Geiser T;Grunewald J;Grutters J;Gudmundsson G;Guenther A;Harai S;Harrison NK;Hirani N;Hodgson U;Kahler CM;Keane MP;Kiter G;Kneussl M;Maher TM;Mogulkoc N;Muller Quernheim J;Neurohr C;Nunes H;Parfrey H;Peros Golubicic T;Polychronopoulos V;Prevot G;Renzoni ER;Robalo Cordeiro C;Saltini C;Skold M;Spagnolo P;Thomeer M;Tomasseti S;Valeyre D;VANCHERI, CARLO;Wallaert B;Wuyts W;Xaubet A.

2012-01-01